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Background/aim: The aim of this study was to gauge whether removal of a specimen with traction during robot-assisted laparoscopic
radical prostatectomy causes a positive surgical margin or not.
Materials and methods: One hundred and sixty-nine patients with localized prostate cancer who underwent robot-assisted laparoscopic
radical prostatectomy from 2009 to 2011 were included in the study. After dividing the patients into two groups, we recorded their
characteristics and pre-op/post-op evaluations.
Results: There were 111 and 58 patients in groups 1 (with traction) and 2 (without traction), respectively. We evaluated the patients’ ages,
follow-up time, body mass index (BMI), prostate-specific antigen (PSA) values, pre-op and post-op Gleason score values, pathological
stage, positive surgical margin rates, and biochemical PSA recurrence rates. There was no statistically significant difference between the
groups for age, pre-op PSA values, BMI, pre-op and post-op Gleason scores, positive surgical margin rates and biochemical recurrence
rates. There was a significant difference between prostate weight, tumor volume, and clinical stage.
Conclusion: Removing the specimen with traction during robot-assisted laparoscopic radical prostatectomy does not cause a positive
surgical margin. The incision should be as small as possible for cosmetic appearance.
Key words: Prostate cancer, radical prostatectomy, specimen, traction

1. Introduction
Robot-assisted laparoscopic radical prostatectomy (RALP)
has become the preferred surgical technique for localized
prostate cancer. One of the most important factors in
its oncological success is the surgical margin status (1).
Positive surgical margin (PSM) status has a possible relation
to the surgeon, surgical technique, and disease burden
(1,2). Our aim was to evaluate the effect of traction, likely
the cause of the PSM, during specimen removal. There are
many studies comparing PSMs according to techniques,
pathological findings, and clinical stage, but we found
none regarding the technique of specimen removal (3).
2. Materials and methods
A total of 169 patients who were treated by RALP for
localized prostate cancer between 2009 and 2011 were
included in this study. All the patients were evaluated
and ethics committee permission was given for each.
* Correspondence: saltinova@yahoo.com

We planned this study to investigate patients with
postoperative PSM but no prostate-specific antigen (PSA)
recurrence. Patients were randomized into two groups, A
and B, according to whether traction was used or not while
removing the specimen. A traction procedure consists of
removing the specimen from a small incision. Nontraction
procedures remove the specimen from an incision larger
than the prostate, which eases the procedure.
Student’s t-test was used for follow-up, age, body mass
index (BMI), PSA, prostate weight, and tumor volume. The
chi-square test was used for Gleason grade, stage, surgical
margin invasion (SMI), and biochemical recurrence rate
(BCR). All values were calculated as mean and SD. SPSS
16 was used.
3. Results
Group A (traction group) had 111 patients, while
group B (nontraction group) had 58. There was a
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statistically significant difference between the groups for
prostate weight, tumor volume, and clinical stage. Age,
BMI, preoperative PSA levels, biopsy Gleason score,
prostatectomy Gleason score, pathological stage, SMI
status, and BCR were similar for both groups. Patients’
preoperative and postoperative characteristics are
summarized in Tables 1 and 2. Although there were pT0
patients in both groups, there was no additional therapy,
such as androgen deprivation therapy, given preoperatively.

4. Discussion
RALP is currently the main surgical technique for
localized prostate cancer. In the United States, 85%
of radical prostatectomies are performed robotically
(4). Generally, PSM rates after different techniques for
radical prostatectomy seem to be equal, but the surgical
technique performed may occasionally affect these rates
(5,6). Oncologic outcomes of robotic surgery are generally
similar with laparoscopic and open surgery (7–10).

Table 1. Preoperative characteristics of patients. *: Statistically significant.
Total (n: 169)

Traction group
(n: 111, 65.7%)

Nontraction Group
(n: 58, 34.3%)

P-value

Follow-up, months, mean ± SD

33.85 ± 8.45

38.62 ± 6.30

24.72 ± 2.26

< 0.001*

Age, years, mean ± SD

61.11 ± 6.65

61.22 ± 6.81

60.91 ± 6.40

0.822

BMI, mean ± SD

26.90 ± 2.97

27.07 ± 2.99

26.50 ± 2.92

0.522

Preoperative PSA, mean ± SD

8.5 ± 5.73

8.88 ± 6.25

7.76 ± 4.56

0.084

Prostate weight, g, mean ± SD

53.20 ± 19.13

50.22 ± 17.39

58.91 ± 21.10

0.037*

Tumor volume, mL, mean ± SD

7.85 ± 1.62

8.80 ± 1.90

6.05 ± 8.54

0.029*

Biopsy Gleason score, n (%)

0.336

≤6

121 (71.6)

84 (49.7) (75.7)

37 (21.9) (63.8)

3+4

26 (15.4)

15 (8.9) (13.5)

11 (6.5) (19)

4+3

9 (5.3)

4 (2.3) (3.6)

5 (3) (8.6)

>7

13 (7.7)

8 (4.7) (7.2)

5 (3) (8.6)

cT1

78 (46.2)

78 (46.2) (70.3)

-

cT2

91 (53.8)

33 (19.5) (29.7)

58 (34.3) (100)

Total (n: 169)

Traction group
(n: 111, 65.7%)

Nontraction group
(n: 58, 34.3%)

9 (5.3)

6 (3.6) (5.4)

3 (1.7) (5.2)

Clinical stage, n (%)

< 0.001*

Table 2. Postoperative findings of patients.

Prostatectomy Gleason score, n (%)
pT0

0.462

≤6

92 (54.4)

66 (39.2) (59.5)

26 (15.4) (44.8)

3+4

40 (23.7)

23 (13.6) (20.7)

17 (10.1) (29.3)

4+3

16 (9.5)

9 (5.3) (8.1)

7 (4.2) (12.1)

>7

12 (7.1)

7 (4.1) (6.3)

5 (3) (8.6)

8 (4.7)

5 (3) (4.5)

3 (1.7) (5.1)

Pathological stage, n (%)
pT0

0.064

pT2

123 (72.8)

75 (44.4) (67.6)

48 (28.4) (82.8)

pT3a

38 (22.5)

31 (18.4) (27.9)

7 (4.1) (12.1)

SMI
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P-value

0.746

Negative

142 (84)

94 (55.6) (84.7)

48 (28.4) (82.8)

Positive

27 (16)

17 (10.1) (15.3)

10 (5.9) (17.2)

BCR

11 (6.5)

8 (4.7) (7.2)

3 (1.8) (5.2)

0.611
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However, some results suggest that the rates are different
for different techniques (11–13). It is well known that the
PSM may be related to the disease burden, surgeon, and
technique. Robotic surgery has some advantages versus
laparoscopic surgery, and these are related to both the
patient and the surgeon. To determine if traction may
cause a PSM, we randomized the patients into two groups
as traction and nontraction. We hypothesized that traction
may cause damage to the prostate capsule and show a
pseudopositive surgical margin. In our study, PSM rates
were similar in both groups. Higher tumor volume and
stage can affect PSM rates (2). Although the traction group
had higher tumor volume rates and lower clinical stage,
the PSM rates were similar. In addition, prostatectomy
Gleason scores were similar for both groups. Higher
preoperative PSA levels (>10 ng/mL) may have an effect
on PSM formation, but our groups had no difference in
PSA levels (14). We included operations performed by
the same person because PSM rates can differ among

surgeons. Some authors have described a “capsular
incision index” to show the damage to the capsule that
may cause pseudopositive surgical margins (2). We think
that, because the traction made by the fourth arm of the
robot may cause a pseudopositive surgical margin, the
pathologist must reveal a possible positive margin via
colored ink; they must also see the capsule of the prostate.
If they do not, this may not be a positive margin. This is
very important because it can affect extra therapy options.
To avoid unnecessary treatment, both the surgeon and the
pathologist must be very careful, as mistakes may not only
increase morbidity, but also cost.
In conclusion, surgical margin status after radical
prostatectomy is an important topic. Surgical technique is
vital for prevention of PSMs, but pathological findings are
equally important for determining additional treatment.
Removing the specimen with traction during RALP does
not cause PSM. The incision should be as small as possible
for cosmetic appearance.
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